Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,796 | 53,989 | 46,832 | 36,810 | 30,159 |
| Marketable Securities | 76,602 | 62,876 | 79,777 | 106,559 | 118,989 |
| TOTAL | $133,094 | $122,252 | $132,153 | $148,404 | $154,947 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 9,443 | 22,797 | 48,795 |
| Other Non-Current Assets | 535 | 581 | 625 | 696 | 736 |
| TOTAL | $535 | $581 | $10,068 | $23,493 | $49,531 |
| Total Assets | $133,629 | $122,833 | $142,221 | $171,897 | $204,478 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,123 | 8,765 | 3,598 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,655 | 554 | 682 | 2,103 | 1,056 |
| Accrued Expenses | 13,451 | 20,688 | 17,676 | 22,758 | 18,259 |
| TOTAL | $29,229 | $30,007 | $21,956 | $24,861 | $19,315 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,924 | 22,396 | 27,053 | 29,882 | 29,528 |
| Other Non-Current Liabilities | 0 | 0 | 39 | 77 | 114 |
| TOTAL | $16,924 | $22,396 | $27,092 | $29,959 | $29,642 |
| Total Liabilities | $46,153 | $52,403 | $49,048 | $54,820 | $48,957 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,228 | 72,213 | 60,573 | 60,573 | 60,573 |
| Common Shares | 7 | 6 | 6 | 6 | 6 |
| Retained earnings | -467,199 | -446,462 | -421,324 | -394,873 | -353,923 |
| Other shareholders' equity | 21 | 83 | 109 | 23 | 15 |
| TOTAL | $87,476 | $70,430 | $93,173 | $117,077 | $155,521 |
| Total Liabilities And Equity | $133,629 | $122,833 | $142,221 | $171,897 | $204,478 |